ipilimumab,nivolumab
bms
[]
another #gi23 update brought to you by #noeticinsight: checkmate 649 affirms 1l nivolumab + chemo for prev-untreated adv gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma 3 yrs of follow-up data show meaningful long-term survival &amp; acceptable safety. 